No abstract
J Nucl Cardiol. 2026 Oct 14:103005. doi: 10.1016/j.nuclcard.2026.103005. Online ahead of print.
NO ABSTRACT
PMID:42874836 | DOI:10.1016/j.nuclcard.2026.103005
Disease-Modifying Therapy Uptake in Transthyretin Amyloid Cardiomyopathy: A 10-Year US Analysis of 77,000 Patients Across Three Approved Agents
Scritto il 14/10/2026